- Home
- GDV vs CERT Comparison
GDV vs CERT Comparison
Compare GDV & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDV
- CERT
- Stock Information
- Founded
- GDV 2003
- CERT 2008
- Country
- GDV United States
- CERT United States
- Employees
- GDV N/A
- CERT N/A
- Industry
- GDV Investment Managers
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- GDV Finance
- CERT Technology
- Exchange
- GDV Nasdaq
- CERT Nasdaq
- Market Cap
- GDV 2.0B
- CERT 2.3B
- IPO Year
- GDV N/A
- CERT 2020
- Fundamental
- Price
- GDV $24.11
- CERT $12.00
- Analyst Decision
- GDV
- CERT Buy
- Analyst Count
- GDV 0
- CERT 6
- Target Price
- GDV N/A
- CERT $15.60
- AVG Volume (30 Days)
- GDV 186.0K
- CERT 2.9M
- Earning Date
- GDV 01-01-0001
- CERT 05-05-2025
- Dividend Yield
- GDV 5.81%
- CERT N/A
- EPS Growth
- GDV N/A
- CERT N/A
- EPS
- GDV N/A
- CERT N/A
- Revenue
- GDV N/A
- CERT $394,498,000.00
- Revenue This Year
- GDV N/A
- CERT $11.41
- Revenue Next Year
- GDV N/A
- CERT $8.78
- P/E Ratio
- GDV N/A
- CERT N/A
- Revenue Growth
- GDV N/A
- CERT 9.37
- 52 Week Low
- GDV $18.04
- CERT $8.64
- 52 Week High
- GDV $23.00
- CERT $17.94
- Technical
- Relative Strength Index (RSI)
- GDV 60.61
- CERT 45.33
- Support Level
- GDV $23.59
- CERT $11.22
- Resistance Level
- GDV $24.21
- CERT $12.30
- Average True Range (ATR)
- GDV 0.36
- CERT 0.67
- MACD
- GDV 0.15
- CERT -0.32
- Stochastic Oscillator
- GDV 94.78
- CERT 18.85
About GDV Gabelli Dividend & Income Trust of Beneficial Interest
Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, in which Financial Services, Food and Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services and others.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.